Idecabtagene vicleucel (ide-cel, bb2121), a BCMA-directed CAR T-cell therapy: Qualitative analyses of pretreatment patient interviews in the KarMMa trial
Braverman, Julia, Moshkovich, Olga, Miera, Matthew, Shah, Selam, Brion, Triza, Devlen, Jennifer, Hege, Kristen, Campbell, Timothy Brandon
Published in Journal of clinical oncology (10.10.2020)
Published in Journal of clinical oncology (10.10.2020)
Get full text
Journal Article
Interviews of Patients (Pts) with Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL) Enrolled in 2 Lisocabtagene Maraleucel (liso-cel) Trials on Their Treatment Experience for 3 Months after Infusion
Siddiqi, Tanya, Jaeger, Ulrich, Moshkovich, Olga, Braverman, Julia, Liu, Fei Fei, Lanar, Sally, Miera, Matthew, Shah, Selam, Devlen, Jennifer, Salles, Gilles
Published in Blood (23.11.2021)
Published in Blood (23.11.2021)
Get full text
Journal Article
Idecabtagene Vicleucel (ide-cel, bb2121), a B-Cell Maturation Antigen-Directed Chimeric Antigen Receptor T Cell Therapy: Qualitative Analyses of Post-Treatment Interviews (Months 6-24) for Patients with Relapsed and Refractory Multiple Myeloma in the Karmma Clinical Trial
Shah, Nina, Delforge, Michel, Rodríguez-Otero, Paula, Moshkovich, Olga, Braverman, Julia, Dhanda, Devender, Lanar, Sally, Devlen, Jennifer, Miera, Matthew, Gerould, Heather, Campbell, Timothy B., Munshi, Nikhil C.
Published in Blood (23.11.2021)
Published in Blood (23.11.2021)
Get full text
Journal Article
Analysis of patient-reported experiences up to 2 years after receiving idecabtagene vicleucel (ide-cel, bb2121) for relapsed or refractory multiple myeloma: Longitudinal findings from the phase 2 KarMMa trial
Delforge, Michel, Otero, Paula Rodríguez, Shah, Nina, Moshkovich, Olga, Braverman, Julia, Dhanda, Devender S., Lanar, Sally, Devlen, Jennifer, Miera, Matthew, Gerould, Heather, Campbell, Timothy B., Munshi, Nikhil C.
Published in Leukemia research (01.06.2023)
Published in Leukemia research (01.06.2023)
Get full text
Journal Article
Qualitative Analysis of the Treatment Experience and Well-Being of Patients with Relapsed/Refractory (R/R) Large B-Cell Lymphoma (LBCL) Enrolled in 2 Trials of Lisocabtagene Maraleucel (liso-cel) during the Initial Stages of Therapy
Siddiqi, Tanya, Jaeger, Ulrich, Moshkovich, Olga, Devlen, Jennifer, Miera, Matthew, Williams, Agnes, Hasskarl, Jens, Liu, Fei Fei, Braverman, Julia, Salles, Gilles
Published in Blood (05.11.2020)
Published in Blood (05.11.2020)
Get full text
Journal Article
Patient experience before and after treatment with idecabtagene vicleucel (ide-cel, bb2121): qualitative analysis of patient interviews in the KarMMa trial
Shah, Nina, Delforge, Michel, San-Miguel, Jesus, Moshkovich, Olga, Braverman, Julia, Dhanda, Devender S., Lanar, Sally, Miera, Matthew, Williams, Agnes, Murphy, Ryan, Devlen, Jennifer, Hege, Kristen, Campbell, Timothy B., Munshi, Nikhil C.
Published in Leukemia research (01.09.2022)
Published in Leukemia research (01.09.2022)
Get full text
Journal Article